Kalaris Therapeutics, Inc. (KLRS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $121.74M | +1875.6% |
| 2024 | $6.16M | -96.8% |
| 2023 | $190.80M | -31.1% |
| 2022 | $277.08M | -3.3% |
| 2021 | $286.59M | -22.7% |
| 2020 | $370.82M | +166.0% |
| 2019 | $139.42M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $121.74M | +1875.6% |
| 2024 | $6.16M | -96.8% |
| 2023 | $190.80M | -31.1% |
| 2022 | $277.08M | -3.3% |
| 2021 | $286.59M | -22.7% |
| 2020 | $370.82M | +166.0% |
| 2019 | $139.42M | — |